Aerpio Pharmaceuticals(AADI) - 2025 Q1 - Quarterly Results

PRESS RELEASE Exhibit 99.1 Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi ...